Saidal

Saidal, established in 1982, is a prominent pharmaceutical and healthcare company headquartered in Algiers, Algeria, operating within the African continent. The company specializes in the comprehensive development, production, and marketing of pharmaceutical products specifically for human use. Operating within the competitive healthcare sector, Saidal leverages its extensive experience and technical expertise to deliver essential medicines and healthcare solutions to its target markets. Its strategic focus on R&D and manufacturing excellence underpins its market position.

With a substantial workforce ranging from 1,000 to 5,000 employees, Saidal maintains a significant operational footprint. The company operates from 1 location, indicating a centralized and focused approach to its manufacturing and distribution processes. To understand the leadership driving these operations and strategic initiatives, you can Meet Saidal's team. This dedicated team is instrumental in guiding the company's strategic direction, ensuring stringent product quality, and fostering innovation across its pharmaceutical development pipeline.

Saidal generates an annual revenue of $337.9M, positioning it as a key player in the African pharmaceutical market and contributing to regional healthcare infrastructure. Its product portfolio is exclusively dedicated to human pharmaceuticals, addressing a wide spectrum of therapeutic areas and patient needs. The company's commitment to advancing public health is underscored by its focus on developing and manufacturing high-quality, accessible medicines. Saidal's strategic emphasis on pharmaceutical innovation, rigorous quality control, and market access solidifies its vital role in the global healthcare landscape.